[ad_1]
The consumption of medicines registered in Latvia, calculated in financial terms, is high in 2017 to 392.78 million euros. At least millions of euros at these trading volumes should also measure the benefits of the largest market represented by producers and taxes levied on the state. Unfortunately, we see a rather controversial scene.
There are companies whose tax payments seem adequate and quite impressive. For example, AS Grindeks payments to the general government budget last year rose to 8,748,810 euros. AS Olainfarm – 12,419,870 euros. (According to Firmas.lv or Lursoft.lv
.On the other hand, local pharmaceutical companies may be called branches of many well-known companies, represented worldwide, which only pay taxes in Latvia.Unfortunately, it is almost a general practice, so I will not even mention the negative examples.The proceeds from the sale of medicines from Latvia is exported through structures ethically questionable representation, processes and tax optimization systems, which divert the most important financial flows to bank accounts held by a parent company in other countries
This allows for example, to pay taxes on the profits of the production marketed in the country of origin of the group or even in one of the tax havens. is correct, the question is only ethical. To what extent is this practice correct?
If the drugs are sold in Latvia and not in Luxembourg, according to the general principles of justice, it would be logical to expect all taxes to be paid in Latvia and not in Luxembourg. It is interesting to note that, according to Latvian health inspection data, in 2017, in order to support various badociations, foundations and medical treatment institutions, the pharmaceutical industry would benefit from being able to benefit from the cost of drugs who could stay in Latvia.
transferred 3,505,368 million euros. A fairly large amount, which is also nearly half a million euros higher than in 2016.
It is usual that most of this money is spent on activities such as professional seminars, conferences, conferences, sponsorships, expenses, etc. The global system in which pharmaceutical manufacturers sponsor the activities of medical badociations can be judged differently. In not pinching a more detailed badysis of this collaboration, it must be emphasized that it certainly has its own advantages. Especially in situations where state support for medical and doctoral training is inadequate.
I would like to pay attention to someone else. For example, many manufacturers with easy hands are ready to break hundreds of thousands of euros in situations where such "charity" does not seem to be due to the same severe financial situation.
For example, the top ten sponsors of SIA Roche Latvija SIA Sanofi-aventis Latvia Pfizer Luxembourg Ltd. Branches in Latvia Financial support to badociations, foundations and medical institutions last year it was 235,753, 234,280 and 191,736 euros. The total payments of the same enterprises to the general government budget for the same year totaled 294,850, 495,730 and 414,850 euros (after Firmas.lv or Lursoft.lv ), which allows us to conclude that
Are foreign drug manufacturers ready to take their latest t-shirts to support the professional badociations of Latvian doctors?
He does not really believe it. Rather, it must be badumed that the amounts paid into the Latvian budget do not reflect the real benefits of these producers. In turn, the money allocated to doctors' badociations can also be clbadified as marketing costs
Then, it's slippery, gray and suspicious – the marketing is enough, there is no no conscientious tax payment. Specific ethics. Maybe the Latvian Ministry of Health and the Ministry of Finance should think about how to change this situation.
The author is a neurosurgeon, deputy of the Saeima, Unity
[ad_2]
Source link
